These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10316738)

  • 21. Specially respecting the living human embryo by adhering to standard human subject experimentation rules.
    Casey SB; Adams NA
    Yale J Health Policy Law Ethics; 2001; 2(1):109, 111-41. PubMed ID: 12664939
    [No Abstract]   [Full Text] [Related]  

  • 22. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 23. Guide to decision-making in institutional review of proposals for human experimentation.
    Himmelsbach CK
    Man Med; 1978; 3(3):201-220. PubMed ID: 12085911
    [No Abstract]   [Full Text] [Related]  

  • 24. Protecting "human guinea pigs".
    Thompson RC
    FDA Consum; 1986 Dec-1987 Jan; 20(10):12-5. PubMed ID: 10311766
    [No Abstract]   [Full Text] [Related]  

  • 25. Exempt research: procedures in the intramural research program of the National Institutes of Health.
    Wichman A; Mills D; Sandler AL
    IRB; 1996; 18(2):3-5. PubMed ID: 11654755
    [No Abstract]   [Full Text] [Related]  

  • 26. Agencies look to improve informed consent.
    Science; 1996 Aug; 273(5275):567. PubMed ID: 11644820
    [No Abstract]   [Full Text] [Related]  

  • 27. The regulation of human experimentation in the United States--a personal odyssey.
    Katz J
    IRB; 1987; 9(1):1-6. PubMed ID: 11649890
    [No Abstract]   [Full Text] [Related]  

  • 28. The Institutional Review Board: a case study of no-risk decisions in health-related research.
    Gortner SR; Heath E; Sanders P
    Nurs Res; 1981; 30(1):21-4. PubMed ID: 6906010
    [No Abstract]   [Full Text] [Related]  

  • 29. Conducting empirical research on informed consent: challenges and questions.
    Sachs GA; Hougham GW; Sugarman J; Agre P; Broome ME; Geller G; Kass N; Kodish E; Mintz J; Roberts LW; Sankar P; Siminoff LA; Sorenson J; Weiss A
    IRB; 2003; Suppl 25(5):S4-S10. PubMed ID: 14870730
    [No Abstract]   [Full Text] [Related]  

  • 30. The peer review system.
    Paque RE
    Fed Proc; 1980 May; 39(7):2350-1. PubMed ID: 7371872
    [No Abstract]   [Full Text] [Related]  

  • 31. The peer review system.
    Homburger F
    Fed Proc; 1980 May; 39(7):2349-50. PubMed ID: 7371871
    [No Abstract]   [Full Text] [Related]  

  • 32. The peer review system.
    Rutman JF
    Fed Proc; 1980 May; 39(7):2349. PubMed ID: 7371870
    [No Abstract]   [Full Text] [Related]  

  • 33. Peer review: a crisis in confidence.
    Kirschstein RL
    Clin Res; 1986 Oct; 34(4):477-83. PubMed ID: 3780138
    [No Abstract]   [Full Text] [Related]  

  • 34. A pilot project: bioethics consultants as non-voting members of IRBs at the National Institutes of Health.
    DeRenzo EG; Wichman A
    IRB; 1990; 12(6):6-8. PubMed ID: 11651266
    [No Abstract]   [Full Text] [Related]  

  • 35. Peer participation in hospital department review.
    Peters DS
    Hosp Adm (Chic); 1975; 20(2):8-15. PubMed ID: 10294905
    [No Abstract]   [Full Text] [Related]  

  • 36. Review of human subjects research: options available to the Institutional Review Board.
    Novak R
    Grants Mag; 1983 Dec; 6(4):225-31. PubMed ID: 10267354
    [No Abstract]   [Full Text] [Related]  

  • 37. Proposals for improving the Peer Review System of the National Institutes of Health.
    Kirschstein RL
    Clin Res; 1977 Dec; 25(5):295-6. PubMed ID: 10304717
    [No Abstract]   [Full Text] [Related]  

  • 38. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 39. Rethinking grant review.
    Nat Neurosci; 2008 Feb; 11(2):119. PubMed ID: 18227790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacist's role as a member of the institutional review board.
    Donehew GR; Schaumberg JP
    Hosp Pharm; 1979 Sep; 14(9):508-9, 512, 515 passim. PubMed ID: 10243913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.